Skip Navigation LinksHome > June 1994 - Volume 34 - Issue 6 > Drug Targeting into the Central Nervous System by Stereotact...
Concepts and Innovations

Drug Targeting into the Central Nervous System by Stereotactic Implantation of Biodegradable Microspheres

Menei, Philippe M.D.; Benoit, Jean-Pierre Ph.D.; Boisdron-Celle, Michelle Ph.D.; Fournier, Dominique M.D.; Mercier, Philippe M.D.; Guy, Gilles M.D.

Collapse Box


CONTROLLED DRUG RELEASE in the central nervous system through an implantable polymeric vector has been developed in recent years. For this purpose, different polymeric devices composed primarily of synthetic biocompatible and biodegradable polymers have been investigated. The first polymeric devices developed were macroscopic implants (monolithic devices), which required open surgery for implantation. Microencapsulation methods, however, allow the production of microparticles or nanoparticles loaded with neuroactive drugs. Because of their size, these micro- or nanoparticles may be easily implanted by stereotaxy in discrete, precise, and functional areas of the brain without causing damage to the surrounding tissue. Presently, this method is most frequently applied in the fields of neuro-oncology and neurodegenerative diseases, but neurologically, the potential applications of drug targeting by stereotactic implantation of drug-loaded particles are legion.

Copyright © by the Congress of Neurological Surgeons


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.